FDA Shows Skin Authority Who’s Boss With Warning For Drug Claims

Yet another skin-care marketer, Skin Authority, has been served with an FDA warning letter for excessive product claims that identify its offerings as drugs. The agency cites statements touting the firm’s ingredient benefits, including collagen production, improved circulation, inflammation relief and hyperpigmentation treatment, consistent with other warnings issued to cosmetics firms in recent months.

FDA’s March 25 warning letter to Skin Authority, LLC offers another illustration of the types of cosmetics claims in the agency’s crosshairs and the challenge skin-care brands face in marketing their products competitively without overstepping regulatory boundaries.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight